Journal of labelled compounds and radiopharmaceuticals p. 363 - 376 (1998)
Update date:2022-08-03
Topics:
Waterhouse, Rikki N.
Gotsick, J. Timothy
Kabalka, George W.
Goodman, Mark M.
O'Brien
[123I]-8-[4-[2-(5-Iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3,8- triazaspiro[4.5]-decan-4-one (1) has been synthesized as a potential ligand for dopamine D2 receptors. This new compound proved to be moderate in lipophilicity (log
View MoreNanjing Chemzam Pharmtech Co., Ltd.
Contact:+86-25-86462165,+86-13915979898
Address:C5-1，6 Maiyue Road，Maigaoqiao，Nanjing，Jiangsu，China
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Nanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
Yurui(Shanghai)Chemical Co.,Ltd
Contact:0086 21-50456736
Address:No.3188 Xiupu Road,Shanghai
Contact:+86-22-83718541
Address:32th Floor, Rongqiao Center Intersection of Changjiang Road and Nankai Six Road Nankai District Tianjin 300102, China
Doi:10.1016/S0040-4020(01)96351-3
(1968)Doi:10.1002/1521-3765(20001215)6:24<4558::AID-CHEM4558>3.0.CO;2-6
(2000)Doi:10.1002/hlca.19840670720
(1984)Doi:10.1016/S0960-894X(98)00194-2
(1998)Doi:10.1016/S0040-4020(98)00467-0
(1998)Doi:10.1055/s-1998-1819
(1998)
